The NHS is about to start doling out ‘the King Kong of weight loss drugs’ to obese patients – the scandal, needless to say, is that not enough people will qualify. The drug, Mounjaro, will be limited to people with a Body Mass Index (BMI) of over 35 and who have at least one medical condition resulting from their excess weight. The National Institute for Health and Care Excellence (NICE) has recommended that 220,000 people be given the drug in the next three years – a small fraction of the 25 per cent of the adult population which is obese.
How dare the NHS be so tight-fisted. It is, of course, a human right to be given drugs to save us from having to eat less. You can’t have fat people (sorry, people living with obesity) being forced to exert their will power and act out of a sense of personal responsibility.
Comments
Join the debate for just $5 for 3 months
Be part of the conversation with other Spectator readers by getting your first three months for $5.
UNLOCK ACCESS Just $5 for 3 monthsAlready a subscriber? Log in